Renal Embolization-Induced Uremic Swine Model for Assessment of Next-Generation Implantable Hemodialyzers
Toxins · 2023
DOI: 10.3390/toxins15090547 ↗Kurz gefasst
Fachartikel in der Zeitschrift Toxins, 2023. Verfasst von Jarrett Moyer und 14 weiteren Autor:innen. Beteiligte Einrichtung: Departments of Bioengineering & Therapeutic Sciences, Surgery, Medicine, and Radiology & Biomedical Imaging, University of California, San Francisco,…. Hauptthemen laut MEDLINE: Kidneys, Artificial, Renal Insufficiency. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIH HHS, NIDDK NIH HHS, NIBIB NIH HHS.
Abstract (Originalsprache)
Reliable models of renal failure in large animals are critical to the successful translation of the next generation of renal replacement therapies (RRT) into humans. While models exist for the induction of renal failure, none are optimized for the implantation of devices to the retroperitoneal vasculature. We successfully piloted an embolization-to-implantation protocol enabling the first implant of a silicon nanopore membrane hemodialyzer (SNMHD) in a swine renal failure model. Renal arterial embolization is a non-invasive approach to near-total nephrectomy that preserves retroperitoneal anatomy for device implants. Silicon nanopore membranes (SNM) are efficient blood-compatible membranes that enable novel approaches to RRT. Yucatan minipigs underwent staged bilateral renal arterial embolization to induce renal failure, managed by intermittent hemodialysis. A small-scale arteriovenous SNMHD prototype was implanted into the retroperitoneum. Dialysate catheters were tunneled externally for connection to a dialysate recirculation pump. SNMHD clearance was determined by intermittent sampling of recirculating dialysate. Creatinine and urea clearance through the SNMHD were 76–105 mL/min/m2 and 140–165 mL/min/m2, respectively, without albumin leakage. Normalized creatinine and urea clearance measured in the SNMHD may translate to a fully implantable clinical-scale device. This pilot study establishes a path toward therapeutic testing of the clinical-scale SNMHD and other implantable RRT devices.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Departments of Bioengineering & Therapeutic Sciences, Surgery, Medicine, and Radiology & Biomedical Imaging, University of California, San Francisco, CA 94143, USA.
- Silicon Kidney, San Ramon, CA 94583, USA.
- Outset Medical, San Jose, CA 95134, USA.
- Division of Nephrology & Hypertension, Vanderbilt University Medical Center, Nashville, TN 37232, USA.
ORCID-Profile: Thomas A Sorrentino, Shuvo Roy
Förderung
- NIH HHS
- NIDDK NIH HHS
- NIBIB NIH HHS
- NIH/NIDDK
- NIH/NIBIB
- Patsy Guglielmo
Zitieren
APA
Moyer, J., Wilson, M. W., Sorrentino, T. A., Santandreu, A., Chen, C., Hu, D., Kerdok, A., Porock, E., Wright, N., Ly, J., Blaha, C., Frassetto, L. A., Fissell, W. H., Vartanian, S. M., & Roy, S. (2023). Renal Embolization-Induced Uremic Swine Model for Assessment of Next-Generation Implantable Hemodialyzers. Toxins. https://doi.org/10.3390/toxins15090547
Vancouver
Moyer J, Wilson MW, Sorrentino TA, Santandreu A, Chen C, Hu D, et al. Renal Embolization-Induced Uremic Swine Model for Assessment of Next-Generation Implantable Hemodialyzers. Toxins. 2023. doi:10.3390/toxins15090547
BibTeX
@article{Moyer2023,
author = {Moyer, Jarrett and Wilson, Mark W and Sorrentino, Thomas A and Santandreu, Ana and Chen, Caressa and Hu, Dean and Kerdok, Amy and Porock, Edward and Wright, Nathan and Ly, Jimmy and Blaha, Charles and Frassetto, Lynda A and Fissell, William H and Vartanian, Shant M and Roy, Shuvo},
title = {Renal Embolization-Induced Uremic Swine Model for Assessment of Next-Generation Implantable Hemodialyzers},
journal = {Toxins},
year = {2023},
doi = {10.3390/toxins15090547}
}
EUVIMED